Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Conditions
Interventions
Intervention1: Group carbetocin: Patients will receive 100 mcg carbetocin IV after delivery of baby
Control Intervention1: Group oxytocin: Patients will receive oxytocin 3 units IV followed by oxytoci
Sponsors
Amrita institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: Parturient between 18 â?? 40 years undergoing elective caesarean section.
Exclusion criteria
Exclusion criteria: H/o significant Cardiac, renal or liver diseases. Hypertensive disorder of pregnancy. Multiple pregnancy. Abnormal placenta. Polyhydramnios. Fibroid complicating pregnancy. Epilepsy. General anaesthesia. Hypersensitivity to study medications and their preservatives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the uterine tone with prophylactic intravenous oxytocin vs. carbetocin in parturients undergoing elective cesarean section under spinal anesthesia. Timepoint: 3 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic effects including heart rate, systolic blood pressure & mean arterial pressure after administration of the drug. Requirement of further uterotonic agents. Adverse effects. Timepoint: Till 15 minutes after delivery of baby | — |
Countries
India
Contacts
Public ContactDilesh Kadapamannil
Amrita Institute of medical sciences
Outcome results
None listed